🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down problematic content and banned related hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, positive reviews and detailed instructions for mixing or administering at home.

Within minutes of entering one community, a seller shared contact information, where most purchases occur. The seller provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, posts show dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.